2005•Chinese Journal of Gastroenterology and HepatologyRequires access

Change and Significance of T cell subsets chronic HBV infected patients

Wei Hong-sha

Open publisher page 0 citations

Abstract

Objective The data of CD4+, CD8+ T cell subsets and HBV DNA were analyzed,To study the change and significance of T cell subsets in chronic HBV infected patients.Methods CD4 and CD8+T cell subsets in peripheral blood mononuclear cells was determined with flow cytometry. The fluroescent quantitative PCR was used to detected the HBV DNA. ELISA kits were used to assay the HBeAg and anti_HBe in serum.Results The number of CD4 T cell in patients with liver cirrhosis (499.75±304.46) and hepatic carcinoma (296.59±279.51) were significantly lower than that of acute hepatitis patients (682.21±299.74,P0.05).The level of CD8+ T cells in patients with liver cirrhosis(303.45±225.84) and hepatic carcinoma(296.59±279.51) were obviously lower than that of patients with acute hepatitis (542.83±277.35,P0.05). There was no difference between the ntt number of CD4+ T cells in 59 cirrhotic patients with anti-HBe positive (477.42±206.39) and those of 35 patients with HBeAg positive (512.37±261.87), however; the number CD8+ T cells of the former group was significantly higher than that of the latter group (was 277.81±212.58;P=0.41); HBV DNA load in sera of cirrhotic patients and hepatic carcinoma patients was remarkable lower than that of chronic severe hepatitis (P=0.05 ).The value of HBV DNA between the group of hepatic carcinoma and cirrhosiswas similar (P= 0.05).Conclusion The level of CD4+ and CD8+ T cells in the group of cirrhosis and hepatic carcinoma are significantly lower than that of acute hepatitis and health positive control. HBV positive patieats with the number of CD8+ T cell being remarkable lower should be excluded from the possible existence of liver cancer.

About this research paper

What this paper is about

Objective The data of CD4+, CD8+ T cell subsets and HBV DNA were analyzed,To study the change and significance of T cell subsets in chronic HBV infected patients.Methods CD4 and CD8+T cell subsets in peripheral blood mononuclear cells was determined with flow cytometry. The fluroescent quantitative PCR was used to detected the HBV DNA. ELISA kits were used to assay the HBeAg and anti_HBe in serum.Results The number of CD4 T cell in patients with liver cirrhosis (499.75±304.46) and hepatic carcinoma (296.59±279.51) were significantly lower than that of acute hepatitis patients (682.21±299.74,P0.05).The level of CD8+ T cells in patients with liver cirrhosis(303.45±225.84) and hepatic carcinoma(296.59±279.51) were obviously lower than that of patients with acute hepatitis (542.83±277.35,P0.05). There was no difference between the ntt number of CD4+ T cells in 59 cirrhotic patients with anti-HBe positive (477.42±206.39) and those of 35 patients with HBeAg positive (512.37±261.87), however; the number CD8+ T cells of the former group was significantly higher than that of the latter group (was 277.81±212.58;P=0.41); HBV DNA load in sera of cirrhotic patients and hepatic carcinoma patients was remarkable lower than that of chronic severe hepatitis (P=0.05 ).The value of HBV DNA between the group of hepatic carcinoma and cirrhosiswas similar (P= 0.05).Conclusion The level of CD4+ and CD8+ T cells in the group of cirrhosis and hepatic carcinoma are significantly lower than that of acute hepatitis and health positive control. HBV positive patieats with the number of CD8+ T cell being remarkable lower should be excluded from the possible existence of liver cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective The data of CD4+, CD8+ T cell subsets and HBV DNA were analyzed,To study the change and significance of T cell subsets in chronic HBV infected patients.Methods CD4 and CD8+T cell subsets in peripheral blood mononuclear cells was determined with flow cytometry. The fluroescent quantitative PCR was used to detected the HBV DNA. ELISA kits were used to assay the HBeAg and anti_HBe in serum.Results The number of CD4 T cell in patients with liver cirrhosis (499.75±304.46) and hepatic carcinoma (296.59±279.51) were significantly lower than that of acute hepatitis patients (682.21±299.74,P0.05).The level of CD8+ T cells in patients with liver cirrhosis(303.45±225.84) and hepatic carcinoma(296.59±279.51) were obviously lower than that of patients with acute hepatitis (542.83±277.35,P0.05). There was no difference between the ntt number of CD4+ T cells in 59 cirrhotic patients with anti-HBe positive (477.42±206.39) and those of 35 patients with HBeAg positive (512.37±261.87), however; the number CD8+ T cells of the former group was significantly higher than that of the latter group (was 277.81±212.58;P=0.41); HBV DNA load in sera of cirrhotic patients and hepatic carcinoma patients was remarkable lower than that of chronic severe hepatitis (P=0.05 ).The value of HBV DNA between the group of hepatic carcinoma and cirrhosiswas similar (P= 0.05).Conclusion The level of CD4+ and CD8+ T cells in the group of cirrhosis and hepatic carcinoma are significantly lower than that of acute hepatitis and health positive control. HBV positive patieats with the number of CD8+ T cell being remarkable lower should be excluded from the possible existence of liver cancer.

Key concepts: Medicine, CD8, Hepatocellular carcinoma, Cirrhosis, HBeAg, Gastroenterology, Flow cytometry, Peripheral blood mononuclear cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Change and Significance of T cell subsets chronic HBV infected patients — Research Paper | ScholarLens